Analytical method validation performed in industry is undergoing a significant transformation—and if your analytical method validation protocol templates haven’t evolved, now is the time to take a closer look.
The United States Pharmacopeia (USP) has proposed a revision to USP <1225>, Validation of Analytical Procedures. This update brings the chapter into closer alignment with ICH Q2(R2) while embracing the lifecycle principles articulated in USP <1220>, Analytical Procedure Lifecycle and the draft USP <1221>, Ongoing Procedure Performance Verification.
But this is more than just an update to guidance—it represents a significant shift in the approach to analytical method validation.
From One-Time Validation to Lifecycle Thinking
Traditionally, analytical method validation has been anchored in Procedure Performance Qualification (PPQ)—a defined study demonstrating that a method meets predefined acceptance criteria.
While this approach remains acceptable, it often provides only a snapshot of performance under fixed conditions, with limited understanding of how method parameters influence results.
The revised USP framework moves beyond this model, introducing a lifecycle-based approach that integrates:
- Analytical Procedure Development (aligned with ICH Q14)
- Execution of PPQ
- Ongoing Procedure Performance Verification (OPPV)
This shift mirrors broader trends seen in ICH Q8(R2)—moving from outcome-based validation toward science- and risk-based understanding.
Minimal vs. Enhanced Approach: A Familiar Parallel
For those familiar with ICH Q8(R2), the parallels are clear.
- A traditional (minimal) approach demonstrates suitability primarily through PPQ, confirming that specifications are met under defined conditions.
- An enhanced approach builds deeper scientific understanding, linking critical method attributes to quality outcomes and establishing a robust, data-driven control strategy.
While both approaches meet regulatory expectations, the enhanced approach provides:
- Greater flexibility for post-validation adjustments
- Stronger justification of method controls
- Improved assurance of consistent performance across conditions
In short, it shifts validation from a compliance exercise where suitability of the control strategy is demonstrated through testing vs specification to a knowledge-driven discipline where there is a scientific understanding of the workings of the control strategy.
Impact on your analytical method validation protocols
So how should organizations respond?
A key takeaway is this: the scope of the analytical method validation protocol must expand beyond PPQ. A modern protocol should reflect the full analytical lifecycle and demonstrate how knowledge and risk management are applied throughout.
Here are four critical elements to incorporate:
- Define a Robust Analytical Target Profile (ATP)
The ATP should clearly articulate:
- Method performance requirements
- Intended use of the method
- The quality expectations of reported results
Critically, it should also reflect a risk-based understanding of quality decisions related to the reported result.
- Capture Knowledge from Method Development
Validation should not start at PPQ—it should build on analytical procedure development.
Protocols should:
- Summarize development studies and findings
- Describe how these results informed the Analytical Control Strategy (ACS)
- Include both statistical evaluation and scientific rationale
- Identify and justify critical method attributes
Ideally, development work should support the definition of a design space, for the analytical method which could be based upon method robustness studies.
- Strengthen PPQ Design and Justification
PPQ remains a critical component—but it must be integrated into the analytical method lifecycle.
Protocols should:
- Clearly justify acceptance criteria in alignment with the ATP
- Use statistically sound study designs
- Demonstrate the method’s ability to effectively discriminate by minimizing the risk of false positive / negative results
- Plan for Ongoing Procedure Performance Verification (OPPV)
Perhaps the most significant evolution is the emphasis on ongoing verification.
A well-designed OPPV strategy should:
- Be risk-based and aligned to method criticality
- Define meaningful method performance indicators, such as:
- Precision and bias
- System suitability
- Control sample performance
- Investigation and invalid rates
The OPPV element of the protocol should Integrate with the firm’s SOPs and knowledge management processes such that the results of continuous monitoring feeds back into:
- Continuous reassessment of the risk associated with the reported result
- Identification of the need for supplemental method development
- Sustained method performance over time
Why This Matters Now
The evolution of USP <1225> reflects a broader regulatory and industry direction:
Validation is no longer a one-time event; it’s an ongoing, science-driven lifecycle.
Organizations that adopt this approach will be better positioned to:
- Demonstrate deep method understanding
- Handle changes to methods with confidence
- Maintain consistent analytical performance over time
Those that don’t risk being constrained by rigid, historically defined validation models.
Final Thought
If your analytical method validation protocols are still centered solely on PPQ, it may be time to rethink your approach.
The future lies in integrating development knowledge, risk management, and continuous verification into a cohesive lifecycle strategy—one that not only meets regulatory expectations but drives smarter, more resilient analytical methods.
For more information or assistance in evolving your method validation on a continuous life cycle basis, Lachman can help! Reach out to us at LCS@lachmanconsultants.com for a consultation.
